Bank of America’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-168,202
| Closed | -$5.79M | – | 6691 |
|
|
2020
Q3 | $5.79M | Sell |
168,202
-495,928
| -75% | -$17.1M | ﹤0.01% | 2455 |
|
|
2020
Q2 | $11.1M | Buy |
664,130
+249,675
| +60% | +$4.17M | ﹤0.01% | 1906 |
|
|
2020
Q1 | $5.98M | Sell |
414,455
-24,645
| -6% | -$355K | ﹤0.01% | 2217 |
|
|
2019
Q4 | $14.7M | Buy |
439,100
+112,886
| +35% | +$3.78M | ﹤0.01% | 1871 |
|
|
2019
Q3 | $6.83M | Buy |
326,214
+69,392
| +27% | +$1.45M | ﹤0.01% | 2475 |
|
|
2019
Q2 | $5.35M | Sell |
256,822
-25,737
| -9% | -$536K | ﹤0.01% | 2710 |
|
|
2019
Q1 | $6.32M | Sell |
282,559
-248,496
| -47% | -$5.55M | ﹤0.01% | 2531 |
|
|
2018
Q4 | $12.7M | Buy |
531,055
+13,679
| +3% | +$327K | ﹤0.01% | 1776 |
|
|
2018
Q3 | $14.1M | Buy |
517,376
+223,270
| +76% | +$6.09M | ﹤0.01% | 1852 |
|
|
2018
Q2 | $7.91M | Buy |
294,106
+48,048
| +20% | +$1.29M | ﹤0.01% | 2331 |
|
|
2018
Q1 | $7.83M | Buy |
246,058
+52,635
| +27% | +$1.68M | ﹤0.01% | 2315 |
|
|
2017
Q4 | $7.31M | Sell |
193,423
-84,943
| -31% | -$3.21M | ﹤0.01% | 2360 |
|
|
2017
Q3 | $6.9M | Buy |
278,366
+69,874
| +34% | +$1.73M | ﹤0.01% | 2506 |
|
|
2017
Q2 | $4.29M | Buy |
208,492
+16,607
| +9% | +$341K | ﹤0.01% | 2744 |
|
|
2017
Q1 | $4.17M | Buy |
191,885
+47,378
| +33% | +$1.03M | ﹤0.01% | 2750 |
|
|
2016
Q4 | $2.96M | Buy |
144,507
+8,060
| +6% | +$165K | ﹤0.01% | 2910 |
|
|
2016
Q3 | $2.05M | Buy |
136,447
+2,167
| +2% | +$32.5K | ﹤0.01% | 3074 |
|
|
2016
Q2 | $1.45M | Sell |
134,280
-11,140
| -8% | -$121K | ﹤0.01% | 3267 |
|
|
2016
Q1 | $1.97M | Buy |
145,420
+129,842
| +833% | +$1.76M | ﹤0.01% | 2981 |
|
|
2015
Q4 | $287K | Buy |
15,578
+6,959
| +81% | +$128K | ﹤0.01% | 4235 |
|
|
2015
Q3 | $218K | Buy |
+8,619
| New | +$218K | ﹤0.01% | 4346 |
|